The novel treatment of this peptide represents a significant advance in the management of diabetes mellitus type 2. Unlike existing medications, tirzepatide targets two pathways – GLP-1 and the GIP hormone – https://tirzepatide-peptide163765.bloggerswise.com/50489473/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment